Special: Belgian Journal of Medical Oncology (BJMO) – Immunotherapy

What?

A multi-sponsored print special issue containing the latest insights regarding oncological treatment with immunotherapy.

Clients

Various pharmaceutical companies

Indication

A wide range of cancers that can be treated with immunotherapy.

Target audience

Medical professionals involved in the field of oncology such as medical oncologists.

Goal

To inform oncology specialists on the latest developments in the field of immunotherapy.

Solution

A printed publication containing the latest data and opinions from experts on the subject of immunotherapy, focusing on practical advice for clinical treatment.

Result

Empowerment of specialists in the clinical management of various types of cancer using immunotherapy.